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Background: Hyaluronic acid has several clinical applications. Recent evidences suggested antimicrobial properties
against several pathogens. The aim of the present survey was to evaluate the effect of hyaluronic acid, alone or in
combination with hyaluronidase, on protechnological or probiotic strains.
Results: The role of hyaluronic acid and hyaluronidase on in vitro growth rate of different lactic acid bacteria was
investigated. Standard methods revealed that low concentrations of hyaluronic acid (0.5-0.125 mg ml-1), and
hyaluronidase at fixed concentration (1.6 mg ml-1), resulted in an increased bacterial strains growth up to 72 hours
whereas higher concentrations of the acid (2 and 1 mg ml-1), and hyaluronidase at the same fixed concentration,
reduced the bacterial growth.
Conclusions: Observations might suggest a possible protective role of both hyaluronidase and low doses of
hyaluronic acid towards some strains, supporting their in vivo proliferation and engraftment after oral administration.
Hyaluronidase introduction into growth medium greatly enhanced the bacterial growth up to 72 hours.
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Hyaluronic acid (HA), a large linear glycosaminoglycan
which is mostly present within extracellular matrix and
whose molecular weight ranges from 8 × 105 (LMWHA) to
2 × 106 (HMWHA) Da [1], is a chain of repeating disacchar-
ide units of D-glucuronic acid and N-acetyl-D-glucosamine
[2]. HA is involved in biological and pathological processes
such as cell adhesion, migration, proliferation, differentiation
[3], vascular diseases and lymphocyte trafficking [4,5].
HA Anti-inflammatory action [6,7], bacteriostatic effect
[8] and antioxidant properties [9] have been recently
highlighted with a wide range of potential therapeutic per-
spectives such as oral, pneumological, dermatological and
urological areas [10]. Healing properties of degradation
products of HA achieved by N-acetylglucosaminic bonds
breakdown, catalysed by the hyaluronidases, have been also
well described in the literature [11]. Hyaluronidase (Hy),
“hydrolases” with a molecular weight of approximately
60000 Da, has been widely used in medicine due to its abil-
ity to reduce extravasation injuries [12], to temporarily* Correspondence: alessandro811@hotmail.it
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reproduction in any medium, provided the orliquefy hyaluronic acid increasing the permeability of vessel
membranes [13] and, as recently observed in Watanabe
heritable hyperlipidaemic rabbits, to cause a partial disrup-
tion of the atherosclerotic plaque surfaces [14]. The hyal-
uronidases can be subdivided into three types [15]: 1)
hyaluronate-4-glycanohydrolases (EC 3.2.1.35), that are
present in mammalian spermatozoa, lysosomes and the
venoms of various insects and snakes; 2) hyaluronate-3-
glycanohydrolases (EC 3.2.1.36), that are produced by
leeches and some hookworms and 3) bacterial hyaluroni-
dases or hyaluronate lyases (EC 4.2.2.1 or EC 4.2.99.1).
Commonly used hyaluronidases are the partially purified
bovine and ovine testicular ones. In spite of such a wide
employment of both HA and Hy, only a few studies have
been conducted to assess their possible combined effects,
if any, on protechnological or probiotic bacteria. Based on
the survey of Ardizzoni et al. (2011) [8], focused on the in-
hibitory effect of HA on a group of pathogenic bacteria
and fungal strains, the aim of the present study was to
evaluate the effects of HA on potential probiotic Lactic
Acid Bacteria (LAB).al Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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LAB engraftment within human gut has been the main
challenge of last decade. However, well standardized
procedures to achieve a long lasting engraftment still
lack. This study, has been focused upon HA- Hy - LAB
interaction to promote bacterial engraftment and feeding
in order to enhance and prolong their beneficial effects.
Firstly, the antimicrobial effect of HA was evaluated by
MIC test in MRS agar. Among strains listed in Table 1,
no one proved to be inhibited by HA even at a concen-
tration of 4 mg ml-1. pH values of HA dilutions ranged
from 6.5 to 7.6, corresponding to an HA concentration
of 4 and 0.0625 mg ml-1, respectively. Moreover, when
Lactobacillus (Lb.) rhamnosus LbGG cells were exposed,
for 30 min, to different levels of HA (4–0.0625 mg ml-1)
a slight increase (about 0.5 log CFU ml-1) in microbial
counts was recorded (data not shown). In other words,
high molecular weight HA did not exert any antimicro-
bial activity when tested on several LAB strains, but, on
contrary, it seemed to enhance the bacterial viability.
To better understand the - strains viability improve-
ment, the ability to ferment HA and its precursor was
evaluated by assessment of pH lowering according to a
conventional procedure. All tested strains, namely three
urease positive streptococci [19] and LbGG, proved to
be able to utilize N-acetyl-D glucosamine, but not D-
glucuronic acid as well as HA.
LbGG is a probiotic strain able to survive to 30 min of
exposure to simulated gastric juice but not to 90 min
[20]. Strain’s survival, evaluated in presence of increasing
concentration of HA (0.0125-1.6 mg ml-1) to simulated
gastric juice for 90 min, highlighted a weak positive
gastro-protective effect that appeared directly correlated
to HA concentration: 1) At 1.6 and 0.8 mg ml-1 HA a
five Log of reduction (from 7 to 2 CFU ml-1) was re-
corded; 2) At 0.4 and 0.2 mg ml-1 HA a 5.5 Log reduc-
tion (from 7 to 1.5 CFU ml-1) was recorded; 3) At HA
concentration lower than 0.1 mg ml-1 no strain survivalTable 1 Strains used in this study and source of isolation
Taxon Strain Source Reference
Lb. rhamnosus LbGG American Type Culture Collection ATCC53103
Lb. casei 491 Provolone del Monaco cheese [16]
Lb. casei 496 Provolone del Monaco cheese [16]
Lb. pentosus OM13 Table olives [17]
Lb. rhamnosus VT1 Parmigiano Reggiano cheese [18]
Lb. rhamnosus RBM526 Parmigiano Reggiano cheese [18]
Lb. rhamnosus RBT739 Parmigiano Reggiano cheese [18]
St. macedonicus 67 Provolone del Monaco cheese [19]
St. thermophilus 309 Provolone del Monaco cheese [19]
St. thermophilus 247 Provolone del Monaco cheese [19]
St. thermophilus 82A Provolone del Monaco cheese [19]was detected. At the used concentrations, HA is not able
to protect the probiotic strain Lb. rhamnosus GG during
a 90 minutes long exposition to simulated gastric juice,
but further studies would be useful to understand if re-
sults may be improved by considering higher concentra-
tion of HA.
A widely accepted in vitro system, which allows simul-
taneous evaluation of several HA doses, was compared
with an innovative method based on the old concept of
dynamic light scattering. By these two approaches com-
parable kinetic curves were obtained. Firstly, tests were
performed on three selected urease positive strains be-
longing to Streptococcus (St.) thermophilus species in
presence of growing concentrations of HA, until 48 h.
As shown in Figure 1, each strain displayed a recurrent
trend in the O.D. kinetics. In detail, curve profiles
dropped after 24 h in all cases, showing a higher marked
decrease when HA concentration was higher. When
lower concentrations of HA were used, O.D. decrease
was limited. Strain 82A behaved as 247 and therefore
was not shown.
Streptococci were even employed for the same set of
trials previously described, but in presence of both HA
and Hy. According to obtained data (Figure 2), strains
displayed after 24 h a completely different behavior:
strains 309 and 247 exhibited an O.D. increase, above all
in presence of higher concentrations of HA, indicating a
bacterial growth enhancement.
Monitoring strains’ activity up to 72 hours revealed a
slight increase of the slope, except in presence of the
highest HA concentration. As shown in Figure 3, each
strain displayed the same trend at the highest HA con-
centration. The curve profile of each strain at 2 mg mL-1
of HA showed a slight decrease after 24 h as for higher
HA concentration. At lower HA concentrations both a
little O.D. increase for 82A strain and a slight O.D. in-
crease for 309 and 247 strains were observed.
These preliminary experiments, demonstrated that
bacterial growth may be influenced by HA concentra-
tion, by Hy concentration and by both of them.
Standard method indicated that a bacterial growth in-
hibition was observable when HA, along with Hy, was
used at concentrations ranging from 2 to 1 mg ml-1.
When considering higher HA concentrations (ranging
from 0.5 to 0.125 mg ml-1), along with Hy, a growth
stimulation up to 72 hours was observed. These results
provide interesting insights about LAB growth kinetics,
and highlight a possible synergistic role of the two chal-
lenged molecules that is likely to be related to the ability
of LAB strains to use the N-acetyl-D glucosamine
monomer as carbon source.
Although speculative, a possible combined role of HA
and hyaluronidase on the bacterial growth was already hy-
pothesized by Starr et al. (2006) [21]. Hy- Streptococcus (St.)
Strain
Time (h)
2 4 6 8 20 24 48
309 - - ** ** ** ** **
247 - ** ** ** * ** **
82A - ** ** ** * ** **
Figure 1 Effects of HA on St. thermophilus strains 309 and 247 until 48 h. Bacteria were employed at a starting concentration of
1 × 106 CFU mL-1. Lower panel: statistical significance between HA-treated and untreated strains. **Highly significant (P < 0.01); *significant
(P < 0.05); - not significant (P > 0.05).
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not with D-glucuronic acid as a sole carbon source. The
same metabolic behavior was recorded in protechnological
and probiotic LAB during this study. Only Hy+ strains
could grow utilizing HA, as a sole carbon source, suggest-
ing that Hy could permit the strain to utilize host HA as an
energy source.
In conclusion, especially high HA concentrations seem
to inhibit bacterial growth, however when low HA con-
centrations are combined with Hy the bacterial growth
seems to be enhanced even beyond 72 hours.
Further studies, in order to understand if the effects of
HA and Hy are strain specific as they seems to be, are
urgently required; specifically, a wider screening of dif-
ferent LAB with interesting features, such as urease
positive and/or hyaluronidase activity, might help to out-
line a new probiotic oral formula with enhanced pre-
biotic gut adherence properties and more effective
therapeutic effect.
Conclusions
The effect of hyaluronic acid on protechnological or
probiotic bacteria has never been evaluated before. In
this study, the effect of hyaluronic acid, alone or incombination with hyaluronidase, on three streptococci
and one probiotic Lactobacillus strain was assessed. By
obtained evidences, a synergistic role of the two mole-
cules was described: when low hyaluronic acid concen-
trations are combined with hyaluronidase, the bacterial
growth appeared greatly enhanced even beyond 72 hours.
This phenomenon could be related to ability of tested
strains to metabolize N-acetyl-D glucosamine, one of the
precursor of hyaluronic acid.
Methods
Media and reagents
MRS (Oxoid LTD, Basingstoke, Hampshire, U.K.) was
employed for bacterial strains growth, strain mainten-
ance and viable count assessment. Sterile saline solutions
of High Molecular Weight HA (1837 kDa, 8 mg ml-1)
where kindly provided by IBSA (Institute Biochemique
SA, Lugano, CH). Hyaluronidase solution (Jaluronidasi
100 I.U., 3.2 mg ml-1) was purchased from Farmacia
Testi snc, Milan, Italy.
Evaluation of minimal inhibitory concentration for HA
Dilutions for HA MIC determination were performed in
sterile deionized water with concentrations ranging from
Figure 2 Effects of HA and Hy on St. thermophilus 309, 247 and 82A until 48 h. Bacteria were employed at a starting concentration of
1 × 106 CFU mL-1. Lower panel: statistical significance between HA-Hy-treated and untreated strains. **Highly significant (P < 0.01); *significant
(P < 0.05); - not significant (P > 0.05).
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50 μl of each dilution were loaded into wells in MRS
agar plates seeded with tested strains. pH values of HA so-
lutions were evaluated by means of pH-meter (Beckman
PHI43). LAB tested are reported in Table 1.
Tolerance to HA of strain Lb. rhamnosus LbGG
(ATCC) was also evaluated. Briefly, strain was subcul-
tured twice in MRS (incubation at 30°C). Cells in early
stationary phase (7.91 ± 0.29 Log CFU ml-1) were col-
lected by centrifugation (6.500 rpm, 10 min), washed
once with sterile Ringer solution (Oxoid) and resus-
pended in the same saline. 200 μl of sterile water solu-
tions of HA (0.0625, 0.125, 0.25, 0.5, 1, 2, 4 and
8 mg ml-1) were added to 200 μl of cell suspensions.
Positive control was realized by adding 200 μl of sterile
saline instead of HA. After 30 min of incubation at 37°C,
living cells were enumerated by drop counting method
(Collins et al., 1989) on MRS agar plates, followed by incu-
bation for 72 h at 37°C.Effect of HA on Lb.GG tolerance to simulated gastric juice
The effect of HA on LbGG tolerance to simulated
gastric juice was determined according to the procedure
reported by Michida et al. (2006) [22]. Briefly, cells were
harvested from cultures in exponential phase of growth
by centrifugation (6.500 rpm, 10 min), washed twice
with sterile saline (0.5%, w/v), and resuspended in the
same sterile saline. Simulated gastric juice was prepared
daily by suspending pepsin (1:10 000, ICN) in sterile
saline (0.5%, w/v) to a final concentration of 3 g l-1 and
adjusting the pH to 2.00 with concentrated HCl using a
pH meter. Aliquots (0.2 ml) of the cell suspensions
were transferred to a 2.0 ml capacity Eppendorf tube,
mixed with 0.3 ml of sterile water solutions of HA
(0.125, 0.25, 0.5, 1, 2, 4, and 8 mg ml-1) and finally
mixed with 1.0 ml of simulated gastric. After incubation
at 37°C for 90 min, cells viability was assayed by drop
counting method [23] on MRS agar plates (incubation
for 72 h at 30°C).
Figure 3 Effects of HA and hy on St. thermophilus 309, 247 and 82A until 72 h. Bacteria were employed at a starting concentration of
1 × 106 CFU mL-1. Lower panel: statistical significance between HA-Hy-treated and untreated strains. **Highly significant (P < 0.01); *significant
(P < 0.05); - not significant (P > 0.05).
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sources
Acid formation by D-glucuronic acid, N-acetyl-D glu-
cosamine, and HA was evaluated in MRS broth without
glucose and meat extract with 2% added carbohydrates,
as filter sterilized water solutions, and 0 · 004% chloro-
phenol red. Media were inoculated with cell suspensions
in sterile saline solution (about 6 log CFU ml-1). Tests
were performed on three urease positive St. thermphilus
strains, namely 309, 82A and 247, and LbGG.
Assessment of HA and Hy effect on LAB strains
The effect of HA and HA in combination with Hy was
evaluated on three St. thermophilus urease positive
strains (309, 247, and 82A). The assay was performed in
96-well microplates (Corning Inc., NY, USA). Firstly,
200 μl of HA +MRS [4, 2, 1, 0,5 and 0.25 mg ml-1] were
added in triplicate in each plate. Then 10 μl of LAB cell
suspensions (working concentrations of about 1 ×
106 CFU ml-1) in sterile saline solution were added.Uninoculated MRS was used as control. Plates were in-
cubated at 37°C in an incubator (Ekort 1500, Angelan-
toni industrie, Milano, Italy). The O.D. values were
measured at a wavelength of 595 nm at 0, 2, 4, 6, 8, 20,
24 and 48 hours by means of a microplate reader
(Tecan, Austria).
For the evaluation of HA-Hy effect, the procedure
above described was repeated by adding to each well
100 μl of Hy [1,8 mg ml-1 in a saline solution] and 10 μl
of each strain (about 1 × 106 CFU ml-1). O.D. values
were measured at 0, 2, 4, 6, 8, 20, 24, 48 and 72 h of in-
cubation at 37°C.
Data analysis
Data obtained from the O.D. readings were used to draw
charts where O.D. was expressed as a function of time.
Each point of the curves is the average value of three
replicates (subtracted of the blank) performed in the
same experimental conditions. Statistical analyses were
performed at 2 h intervals. At each time, analysis of
Di Cerbo et al. BMC Microbiology 2013, 13:243 Page 6 of 6
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carried out to assess overall differences in O.D. readings
obtained from different strains in relation to the control.
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